Torsten Hoof

General Manager of International

Joined Exact Sciences: 2019

Key Responsibility: Oversees international efforts for the company.

Previous Employment: Torsten Hoof joined Genomic Health in 2017 as Senior Vice President, International. Torsten was also the Vice President and Head of Oncology EMEA at Baxalta, where he built the company’s oncology presence in Europe. Torsten was also the European General Manager for Endocyte, where he established its European organization designed to bring an innovative, precision medicine solution to patients with ovarian cancer. During his 10 years at Bristol-Myers Squibb, he led the global haemato-oncology franchise and was EMEA General Manager and Vice President for HIV and Primary Care. In his career with Roche, Torsten led the Tamiflu launch as a Global Business Leader and established Roche’s German leadership position in Virology. Torsten also served as an Independent Director at HRA Pharma until its acquisition by Goldman-Sachs/Astorg in 2016.

Education: PhD, Masters (Distinction), University of Hannover, Germany. Alumnus of the Boehringer Ingelheim Fonds, Germany.

7Asset 1

“Having spent my professional life bringing innovation to medical care, I am passionate about helping patients, physicians and societies recognize and capture the full value of personalized medicine and obtaining smarter answers across the cancer journey. That is why I’m thrilled to join Exact Sciences. Through our science, people, and global reach, we can bring life-changing benefits to cancer patients around the world.”

Leading the battle against cancer, together.

Exact Sciences and Genomic Health have teamed up to take cancer on, together. By combining our leading portfolio of products, we are continuing our relentless pursuit of earlier detection and smarter answers.

Read the official announcementLearn more About Us